Users of this system, can login to view this document.

Login

Enter the following information to request a copy of the document from the responsible person.

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States medicare population

This email address is used for sending the document.